Formerly About Advanced Micro Devices Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: J_F_Shepard who wrote (564851)	5/6/2010 6:29:15 AM
From: Brumar89	Read Replies (1) of 1575797

NHS Denies Cancer Drug as Too Costly (But Don’t Call it a Death Panel) John on May 5, 2010 at 7:09 pm Sorta sounds like what I imagine a death panel might do (if one existed): Thousands of cancer sufferers are set to be denied a ‘miracle’ drug on the NHS that is routinely used in virtually every other Western country. The Government’s rationing body says Avastin is not cost-effective despite evidence that it can prolong the lives of bowel cancer patients by more than two years. [...] When used for bowel cancer Avastin costs around £18,000 for a course of ten months’ treatment given with chemotherapy. But a complex formula used by NICE, which looks at quality of life and overall cost effectiveness, says the annual cost is £36,000. This exceeds the maximum limit set by the body of £30,000, a figure which has not changed in ten years despite inflation. Ah, well, what’s a couple years of life compared to a socialist utopia? verumserum.com Interesting to know exactly what a life is worth in Britain. No indexing for inflation I note.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next